KACI DYMOND: Open Payments
NPI 1699360370 · INVERNESS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$825 in 30 payments from 12 companies in 2025. Trend: 2023 $472 · 2024 $780 · 2025 $825
Food & beverage: $825
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 5 | $165 |
| PFIZER INC. | 3 | $162 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $95 |
| AstraZeneca Pharmaceuticals LP | 5 | $95 |
| Alnylam Pharmaceuticals Inc. | 2 | $72 |
| Amgen Inc. | 4 | $61 |
| Merck Sharp & Dohme LLC | 2 | $50 |
| Esperion Therapeutics, Inc. | 2 | $38 |
| Novartis Pharmaceuticals Corporation | 2 | $32 |
| Novo Nordisk Inc | 1 | $20 |
Products named: WATCHMAN FLX, VYNDAQEL, LifeVest, FARXIGA, ONPATTRO, Repatha, NEXLETOL, LEQVIO.
Industry payments across FL — which companies pay providers there.
